Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced NSCLC × Nivolumab × Thoracic × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 240 Lung Neoplasms 75 Melanoma 56 Carcinoma, Renal Cell 43 Small Cell Lung Carcinoma 33 Colorectal Neoplasms 27 Squamous Cell Carcinoma of Head and Neck 23 Neoplasms 23 Carcinoma, Transitional Cell 23 Triple Negative Breast Neoplasms 22 Neoplasm Metastasis 20 Carcinoma, Hepatocellular 19 Ovarian Neoplasms 17 Mesothelioma 16 Mesothelioma, Malignant 15 Pancreatic Neoplasms 14 Stomach Neoplasms 13 Breast Neoplasms 13 Uterine Cervical Neoplasms 11 Urinary Bladder Neoplasms 10 Head and Neck Neoplasms 10 Kidney Neoplasms 9 Carcinoma, Merkel Cell 9 Adenocarcinoma of Lung 8 Esophageal Neoplasms 7 Endometrial Neoplasms 7 Lymphoma 6 Carcinoma, Squamous Cell 6 Brain Neoplasms 6 Prostatic Neoplasms 5

Interventions

Radiotherapy 4 Immune Checkpoint Inhibitors 4 famitinib 1 camrelizumab 1 aflutinib 1 Oxaliplatin 1 Nivolumab 1 Ipilimumab 1 Docetaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04043195 2025-05-28

NSCLC

University of California, San Diego

Phase 1/2 Active not recruiting

Advanced NSCLC

Data powered by HemOnc (CC BY 4.0) Colophon ⚡